Supplementary Tables S1-S11 from Adult Low-Hypodiploid Acute Lymphoblastic Leukemia Emerges from Preleukemic <i>TP53</i>-Mutant Clonal Hematopoiesis

Supplementary Tables S1-S11 from Adult Low-Hypodiploid Acute Lymphoblastic Leukemia Emerges from Preleukemic <i>TP53</i>-Mutant Clonal Hematopoiesis

<p>Supplementary Table 1. Karyotypes of LH-ALL patients at diagnosis. Supplementary Table 2. Somatic variants detected in LH-ALL patients at diagnosis. Supplementary Table 3. ARCH related variants detected in LH-ALL patients at remission. Supplementary Table 4. Minimal residual disease values...

Disgrifiad llawn

Wedi'i Gadw mewn:

Manylion Llyfryddiaeth
Prif Awdur:	Rathana Kim (15135915) (author)
Awduron Eraill:	Hugo Bergugnat (15135918) (author), Lise Larcher (15135921) (author), Matthieu Duchmann (15049433) (author), Marie Passet (15135924) (author), Stéphanie Gachet (15118876) (author), Wendy Cuccuini (15135927) (author), Marina Lafage-Pochitaloff (15135930) (author), Cédric Pastoret (15135933) (author), Nathalie Grardel (15135936) (author), Vahid Asnafi (15135939) (author), Beat W. Schäfer (15135942) (author), Eric Delabesse (15047352) (author), Raphaël Itzykson (15135945) (author), Lionel Adès (15049442) (author), Yosr Hicheri (15135948) (author), Yves Chalandon (15018422) (author), Carlos Graux (15135951) (author), Patrice Chevallier (15135954) (author), Mathilde Hunault (15135957) (author), Thibaut Leguay (15135960) (author), Françoise Huguet (15047328) (author), Véronique Lhéritier (15135963) (author), Hervé Dombret (15049448) (author), Jean Soulier (15135966) (author), Philippe Rousselot (15135969) (author), Nicolas Boissel (15135972) (author), Emmanuelle Clappier (15118873) (author)
Cyhoeddwyd:	2025
Pynciau:	Cancer Molecular and Cellular Biology Therapeutic Research and Development Methods and Technology Genome Biology Hematological Cancers Leukemias Single Cell Technologies Translational Research
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg

Suppl Data 2 from Whole Slide Imaging-Based Prediction of <i>TP53</i> Mutations Identifies an Aggressive Disease Phenotype in Prostate Cancer
gan: Marija Pizurica (17060224)
Cyhoeddwyd: (2025)

Suppl. Data 1 from Whole Slide Imaging-Based Prediction of <i>TP53</i> Mutations Identifies an Aggressive Disease Phenotype in Prostate Cancer
gan: Marija Pizurica (17060224)
Cyhoeddwyd: (2025)

Supplemental Table S3 from Clonal Hematopoiesis in Young Women Treated for Breast Cancer
gan: Christopher J. Gibson (15907642)
Cyhoeddwyd: (2025)

Supplemental Table S4 from Clonal Hematopoiesis in Young Women Treated for Breast Cancer
gan: Christopher J. Gibson (15907642)
Cyhoeddwyd: (2025)

Table S1-S3 from Clonal Hematopoiesis Mutations in Patients with Lung Cancer Are Associated with Lung Cancer Risk Factors
gan: Wei Hong (432102)
Cyhoeddwyd: (2025)

Supplementary Figure 1 from Polymorphisms in <i>Cyclooxygenase</i>, <i>Lipoxygenase</i>, and <i>TP53</i> Genes Predict Colorectal Polyp Risk Reduction by Aspirin in the seAFOod Polyp Prevention Trial
gan: John R. Davies (17314989)
Cyhoeddwyd: (2025)

Supplementary Figure 2 from Polymorphisms in <i>Cyclooxygenase</i>, <i>Lipoxygenase</i>, and <i>TP53</i> Genes Predict Colorectal Polyp Risk Reduction by Aspirin in the seAFOod Polyp Prevention Trial
gan: John R. Davies (17314989)
Cyhoeddwyd: (2025)

Supplementary Figure 3 from Polymorphisms in <i>Cyclooxygenase</i>, <i>Lipoxygenase</i>, and <i>TP53</i> Genes Predict Colorectal Polyp Risk Reduction by Aspirin in the seAFOod Polyp Prevention Trial
gan: John R. Davies (17314989)
Cyhoeddwyd: (2025)

Supplementary Table 2 from Polymorphisms in <i>Cyclooxygenase</i>, <i>Lipoxygenase</i>, and <i>TP53</i> Genes Predict Colorectal Polyp Risk Reduction by Aspirin in the seAFOod Polyp Prevention Trial
gan: John R. Davies (17314989)
Cyhoeddwyd: (2025)

Supplementary Figure S11 from Elucidating the Genetic Landscape of Oral Leukoplakia to Predict Malignant Transformation
gan: Leon J. Wils (15055780)
Cyhoeddwyd: (2025)

Table 1 from Addressing Common Misuses and Pitfalls of <i>P</i> values in Biomedical Research
gan: Ming Wang (8809334)
Cyhoeddwyd: (2025)

Supplementary Figure 1 from <i>ALK</i> Amplification and Rearrangements Are Recurrent Targetable Events in Congenital and Adult Glioblastoma
gan: Anne-Florence Blandin (15056366)
Cyhoeddwyd: (2025)

Supplementary Figure 2 from <i>ALK</i> Amplification and Rearrangements Are Recurrent Targetable Events in Congenital and Adult Glioblastoma
gan: Anne-Florence Blandin (15056366)
Cyhoeddwyd: (2025)

Supplementary Figure 3 from <i>ALK</i> Amplification and Rearrangements Are Recurrent Targetable Events in Congenital and Adult Glioblastoma
gan: Anne-Florence Blandin (15056366)
Cyhoeddwyd: (2025)

Supplementary Figure 4 from <i>ALK</i> Amplification and Rearrangements Are Recurrent Targetable Events in Congenital and Adult Glioblastoma
gan: Anne-Florence Blandin (15056366)
Cyhoeddwyd: (2025)

Supplementary Figure 5 from <i>ALK</i> Amplification and Rearrangements Are Recurrent Targetable Events in Congenital and Adult Glioblastoma
gan: Anne-Florence Blandin (15056366)
Cyhoeddwyd: (2025)

Supplementary Figure 6 from <i>ALK</i> Amplification and Rearrangements Are Recurrent Targetable Events in Congenital and Adult Glioblastoma
gan: Anne-Florence Blandin (15056366)
Cyhoeddwyd: (2025)

Supplementary Tables S1-S10 from <i>ACTA2</i> Expression Predicts Survival and Is Associated with Response to Immune Checkpoint Inhibitors in Gastric Cancer
gan: Sunho Park (15053897)
Cyhoeddwyd: (2025)

Supplementary Tables 1-8 from <i>ALK</i> Amplification and Rearrangements Are Recurrent Targetable Events in Congenital and Adult Glioblastoma
gan: Anne-Florence Blandin (15056366)
Cyhoeddwyd: (2025)

Supplementary Tables from Biallelic <i>Dicer1</i> Mutations in the Gynecologic Tract of Mice Drive Lineage-Specific Development of <i>DICER1</i> Syndrome–Associated Cancer
gan: Yemin Wang (17315078)
Cyhoeddwyd: (2025)

Figure 1 from <i>In Vivo</i> Modeling of Patient Genetic Heterogeneity Identifies New Ways to Target Cholangiocarcinoma
gan: Nicholas T. Younger (14956251)
Cyhoeddwyd: (2025)

Figure 2 from <i>In Vivo</i> Modeling of Patient Genetic Heterogeneity Identifies New Ways to Target Cholangiocarcinoma
gan: Nicholas T. Younger (14956251)
Cyhoeddwyd: (2025)

Figure 3 from <i>In Vivo</i> Modeling of Patient Genetic Heterogeneity Identifies New Ways to Target Cholangiocarcinoma
gan: Nicholas T. Younger (14956251)
Cyhoeddwyd: (2025)

Figure 4 from <i>In Vivo</i> Modeling of Patient Genetic Heterogeneity Identifies New Ways to Target Cholangiocarcinoma
gan: Nicholas T. Younger (14956251)
Cyhoeddwyd: (2025)

Supplemental Tables 1-8 from Colorectal Cancer Metastases in the Liver Establish Immunosuppressive Spatial Networking between Tumor-Associated <i>SPP1</i><sup>+</sup> Macrophages and Fibroblasts
gan: Anuja Sathe (15028097)
Cyhoeddwyd: (2025)

Supplementary Table S3 from Loss of <i>CDKN2A</i> Cooperates with <i>WWTR1(TAZ)–CAMTA1</i> Gene Fusion to Promote Tumor Progression in Epithelioid Hemangioendothelioma
gan: Caleb N. Seavey (15056489)
Cyhoeddwyd: (2025)

Supplementary Table S4 from Loss of <i>CDKN2A</i> Cooperates with <i>WWTR1(TAZ)–CAMTA1</i> Gene Fusion to Promote Tumor Progression in Epithelioid Hemangioendothelioma
gan: Caleb N. Seavey (15056489)
Cyhoeddwyd: (2025)

Supplementary Table from Functional Analysis of <i>MET</i> Exon 14 Skipping Alteration in Cancer Invasion and Metastatic Dissemination
gan: Feng Wang (44414)
Cyhoeddwyd: (2025)

Supplementary Table from Functional Analysis of <i>MET</i> Exon 14 Skipping Alteration in Cancer Invasion and Metastatic Dissemination
gan: Feng Wang (44414)
Cyhoeddwyd: (2025)

Supplementary Table from Functional Analysis of <i>MET</i> Exon 14 Skipping Alteration in Cancer Invasion and Metastatic Dissemination
gan: Feng Wang (44414)
Cyhoeddwyd: (2025)

Supplementary Table from Functional Analysis of <i>MET</i> Exon 14 Skipping Alteration in Cancer Invasion and Metastatic Dissemination
gan: Feng Wang (44414)
Cyhoeddwyd: (2025)

Figure S1 from <i>De Novo</i> and Histologically Transformed Small-Cell Lung Cancer Is Sensitive to Lurbinectedin Treatment Through the Modulation of EMT and NOTCH Signaling Pathways
gan: Subhamoy Chakraborty (16648124)
Cyhoeddwyd: (2025)

Figure S2 from <i>De Novo</i> and Histologically Transformed Small-Cell Lung Cancer Is Sensitive to Lurbinectedin Treatment Through the Modulation of EMT and NOTCH Signaling Pathways
gan: Subhamoy Chakraborty (16648124)
Cyhoeddwyd: (2025)

Figure S3 from <i>De Novo</i> and Histologically Transformed Small-Cell Lung Cancer Is Sensitive to Lurbinectedin Treatment Through the Modulation of EMT and NOTCH Signaling Pathways
gan: Subhamoy Chakraborty (16648124)
Cyhoeddwyd: (2025)

Supplementary Data 1 from Unique Spectrum of Activating <i>BRAF</i> Alterations in Prostate Cancer
gan: Alex Chehrazi-Raffle (17079582)
Cyhoeddwyd: (2025)

Supplementary Figure 1 from Unique Spectrum of Activating <i>BRAF</i> Alterations in Prostate Cancer
gan: Alex Chehrazi-Raffle (17079582)
Cyhoeddwyd: (2025)

Supplementary Tables from <i>In Vivo</i> Modeling of CLL Transformation to Richter Syndrome Reveals Convergent Evolutionary Paths and Therapeutic Vulnerabilities
gan: Elisa ten Hacken (15136187)
Cyhoeddwyd: (2025)

Supplementary Tables 1-3 from <i>De Novo</i> and Histologically Transformed Small-Cell Lung Cancer Is Sensitive to Lurbinectedin Treatment Through the Modulation of EMT and NOTCH Signaling Pathways
gan: Subhamoy Chakraborty (16648124)
Cyhoeddwyd: (2025)

Supplementary Data 1 from Early Changes in Circulating Cell-Free <i>KRAS</i> G12C Predict Response to Adagrasib in KRAS Mutant Non–Small Cell Lung Cancer Patients
gan: Cloud P. Paweletz (14960112)
Cyhoeddwyd: (2025)

Climate-driven emergence of nitrogen export hotspots in northern China's croplands
gan: jie Qiu (19440868)
Cyhoeddwyd: (2025)

Cannot write session to /tmp/vufind_sessions/sess_eobcqq57et4qqr7es8i1ft2bbt